An Integrative Meta-analysis of MicroRNAs in Hepatocellular Carcinoma
Mahmoud ElHefnawi;Bangli Soliman;Nourhan Abu-Shahba;Marwa Amer;Centre of Excellence for Advanced Sciences,Informatics and Systems Department,National Research Centre;Stem Cells Research Group,Centre of Excellence for Advanced Sciences,Medical Molecular Genetics Department,National Research Centre;Biology Department,American University in Cairo (AUC);Faculty of Biotechnology,Misr University for Science and Technology (MUST);
We aimed to shed new light on the roles of microRNAs(miRNAs) in liver cancer using an integrative in silico bioinformatics analysis. A new protocol for target prediction and functional analysis is presented and applied to the 26 highly differentially deregulated miRNAs in hepatocellular carcinoma. This framework comprises:(1) the overlap of prediction results by four out of fve target prediction tools, including TargetScan, PicTar, miRanda, DIANA-microT and miRDB(combining machine-learning, alignment, interaction energy and statistical tests in order to minimize false positives),(2) evidence from previous microarray analysis on the expression of these targets,(3) gene ontology(GO) and pathway enrichment analysis of the miRNA targets and their pathways and(4) linking these results to oncogenesis and cancer hallmarks. This yielded new insights into the roles of miRNAs in cancer hallmarks. Here we presented several key targets and hundreds of new targets that are signifcantly enriched in many new cancer-related hallmarks. In addition, we also revealed some known and new oncogenic pathways for liver cancer. These included the famous MAPK, TGFb and cell cycle pathways. New insights were also provided into Wnt signaling, prostate cancer, axon guidance and oocyte meiosis pathways. These signaling and developmental pathways crosstalk to regulate stem cell transformation and implicate a role of miRNAs in hepatic stem cell deregulation and cancer development. By analyzing their complete interactome, we proposed new categorization for some of these miRNAs as either tumor-suppressors or oncomiRs with dual roles. Therefore some of these miRNAs may be addressed as therapeutic targets or used as therapeutic agents. Such dual roles thus expand the view of miRNAs as active maintainers of cellular homeostasis.